Robeco Schweiz AG Has $13.89 Million Stake in Medtronic PLC (NYSE:MDT)

Robeco Schweiz AG increased its stake in Medtronic PLC (NYSE:MDT - Free Report) by 6.0% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 154,543 shares of the medical technology company's stock after purchasing an additional 8,736 shares during the period. Robeco Schweiz AG's holdings in Medtronic were worth $13,887,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also recently added to or reduced their stakes in MDT. Brighton Jones LLC increased its stake in Medtronic by 1,368.0% in the 4th quarter. Brighton Jones LLC now owns 39,989 shares of the medical technology company's stock valued at $3,194,000 after buying an additional 37,265 shares during the last quarter. Proficio Capital Partners LLC acquired a new position in Medtronic during the fourth quarter valued at approximately $13,132,000. AGF Management Ltd. bought a new position in Medtronic in the fourth quarter valued at approximately $335,000. Natural Investments LLC bought a new stake in shares of Medtronic during the 4th quarter worth approximately $291,000. Finally, PFG Advisors boosted its holdings in shares of Medtronic by 8.4% in the 4th quarter. PFG Advisors now owns 2,673 shares of the medical technology company's stock valued at $214,000 after buying an additional 208 shares during the last quarter. Institutional investors own 82.06% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities analysts recently weighed in on the stock. Evercore ISI boosted their target price on shares of Medtronic from $103.00 to $106.00 and gave the stock an "outperform" rating in a report on Tuesday. Leerink Partnrs raised shares of Medtronic to a "strong-buy" rating in a report on Monday, June 16th. Wolfe Research upgraded Medtronic from an "underperform" rating to a "peer perform" rating in a report on Monday, June 30th. Robert W. Baird dropped their price objective on Medtronic from $94.00 to $92.00 and set a "neutral" rating on the stock in a research note on Thursday, May 22nd. Finally, Citigroup lifted their target price on Medtronic from $98.00 to $99.00 and gave the stock a "buy" rating in a research note on Wednesday. Nine investment analysts have rated the stock with a hold rating, nine have assigned a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $97.47.

Medtronic Stock Up 0.4%

Shares of NYSE MDT opened at $89.39 on Friday. The company has a 50 day simple moving average of $85.66 and a 200 day simple moving average of $86.76. The company has a debt-to-equity ratio of 0.53, a current ratio of 1.85 and a quick ratio of 1.42. Medtronic PLC has a 1 year low of $76.68 and a 1 year high of $96.25. The firm has a market cap of $114.65 billion, a PE ratio of 24.69, a price-to-earnings-growth ratio of 2.40 and a beta of 0.80.

Medtronic (NYSE:MDT - Get Free Report) last released its quarterly earnings results on Wednesday, May 21st. The medical technology company reported $1.62 EPS for the quarter, beating analysts' consensus estimates of $1.58 by $0.04. Medtronic had a return on equity of 14.54% and a net margin of 13.90%. The firm had revenue of $8.93 billion for the quarter, compared to analyst estimates of $8.81 billion. During the same quarter in the previous year, the company posted $1.46 EPS. The business's revenue was up 3.9% on a year-over-year basis. On average, research analysts forecast that Medtronic PLC will post 5.46 EPS for the current year.

Medtronic Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 11th. Shareholders of record on Friday, June 27th will be issued a dividend of $0.71 per share. This is an increase from Medtronic's previous quarterly dividend of $0.70. This represents a $2.84 dividend on an annualized basis and a yield of 3.18%. The ex-dividend date is Friday, June 27th. Medtronic's dividend payout ratio (DPR) is presently 78.45%.

Medtronic Company Profile

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.